Finch Therapeutics Group, Inc. (FNCH)
Total Valuation
FNCH has a market cap or net worth of $110.81 million. The enterprise value is $9.62 million.
| Market Cap | 110.81M |
| Enterprise Value | 9.62M |
Important Dates
The latest earnings date was Monday, May 16, 2022, before market open.
| Last Earnings Date | May 16, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
FNCH has 47.56 million shares outstanding. The number of shares has increased by 238.69% in one year.
| Shares Outstanding | 47.56M |
| Shares Change (YoY) | +238.69% |
| Shares Change (QoQ) | +21.24% |
| Owned by Insiders (%) | 51.37% |
| Owned by Institutions (%) | 22.27% |
| Float | 22.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.23 |
| PB Ratio | 0.62 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.31, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.31 |
| Quick Ratio | 6.38 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -33.10%, which is considered low. The company has a ROIC of -112.20%.
| Return on Equity (ROE) | -33.10% |
| Return on Assets (ROA) | -30.10% |
| Return on Capital (ROIC) | -112.20% |
| Revenue Per Employee | $81,127 |
| Profits Per Employee | -$363,735 |
| Employee Count | 189 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| Total Price Change | -89.46% |
| 50-Day Moving Average | 2.72 |
| 200-Day Moving Average | 7.73 |
| Average Volume (30 Days) | 961,857 |
Short Selling Information
The latest short interest is 755,194, so 1.59% of the outstanding shares have been sold short.
| Short Interest | 755,194 |
| Short % of Shares Out | 1.59% |
| Short % of Float | 3.37% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, FNCH had revenue of $15.33 million and -68.75 million in losses. Earnings per share was -$1.45.
| Revenue | 15.33M |
| Gross Profit | 15.33M |
| Operating Income | -70.59M |
| Net Income | -68.75M |
| EBITDA | -65.49M |
| EBIT | -68.75M |
| Earnings Per Share (EPS) | -$1.45 |
Balance Sheet
The company has $106.93 million in cash and $5.74 million in debt, giving a net cash position of $101.19 million or $2.13 per share.
| Cash & Cash Equivalents | 106.93M |
| Total Debt | 5.74M |
| Net Cash | 101.19M |
| Net Cash Per Share | $2.13 |
| Book Value | 179.79M |
| Book Value Per Share | 3.78 |
| Working Capital | 105.86M |
Cash Flow
In the last 12 months, operating cash flow was -$77.57 million and capital expenditures -$8.01 million, giving a free cash flow of -$85.57 million.
| Operating Cash Flow | -77.57M |
| Capital Expenditures | -8.01M |
| Free Cash Flow | -85.57M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -460.39% and -448.35%.
| Gross Margin | 100.00% |
| Operating Margin | -460.39% |
| Pretax Margin | n/a |
| Profit Margin | -448.35% |
| EBITDA Margin | -427.11% |
| EBIT Margin | -448.40% |
| FCF Margin | -558.08% |
Dividends & Yields
FNCH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -62.04% |
| FCF Yield | -77.22% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -238.69% |
| Shareholder Yield | -238.69% |
Analyst Forecast
The average price target for FNCH is $24.14, which is 936.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $24.14 |
| Price Target Difference | 936.05% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |